Breaking News
Get 40% Off 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

Avalon Globocare Corp (ALBT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Avalon Globocare's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.2950 -0.0250    -7.81%
31/05 - Closed. Currency in USD ( Disclaimer )
After Hours
0.2987
+0.0037
+1.2542%
19:57:30 - Real-time Data
  • Volume: 51,192
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.2841 - 0.3400
Type:  Equity
Market:  United States
Avalon Globocare 0.2950 -0.0250 -7.81%

Avalon Globocare Corp Company Profile

 
Get an in-depth profile of Avalon Globocare Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Providers & Services
SectorHealthcare
Employees

5

Equity Type

ORD

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. The company focuses to develop diagnostics and clinical laboratory services through ownership acquisition or license rights in precision diagnostic assets, genetic testing and clinical laboratory companies through joint ventures, and share ownership structures or distribution rights. The company was founded in 2016 and is headquartered in Freehold, New Jersey.

Contact Information

Address 4400 Route 9 South Suite 3100
Freehold, 07728
United States
Phone 732 780 4400
Fax -

Top Executives

Name Age Since Title
Robert S. Langer 74 2019 Member of Scientific & Clinical Advisory Board
Yen-Michael S. Hsu - - Member of Scientific & Clinical Advisory Board
Wenchun Qu - - Member of Scientific & Clinical Advisory Board
Peihua Peggy Lu - - Member of Scientific & Clinical Advisory Board
Hongxing Liu - 2022 Member of Scientific and Clinical Advisory Board
Lourdes Felix 55 2023 Independent Director
Wenzhao Lu 64 2016 Chairman of the Board
William B. Stilley 55 2018 Independent Director
James L. Gajewski - 2018 Head of Scientific & Clinical Advisory Board
David K. Jin 55 2016 CEO, President & Director
Shahin Rafii - - Member of Scientific & Clinical Advisory Board
Tevi Troy 55 2018 Independent Director
Wilbert J. Tauzin 79 2017 Director
Xin Lin - - Member of Scientific & Clinical Advisory Board
Uwe. B Sleytr - 2020 Member of Scientific & Clinical Advisory Board
Steven Andrew Sanders 78 2018 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALBT Comments

Write your thoughts about Avalon Globocare Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email